Hims & Hers Health, Inc. reported a 57% year-over-year increase in revenue to $226.7 million for Q3 2023. The company achieved Adjusted EBITDA profitability of $12.3 million and grew its subscriber base to 1.4 million. They raised their full year 2023 revenue guidance to a range of $868 million to $873 million and Adjusted EBITDA guidance to a range of $43 million to $46 million.
Revenue increased by 57% year-over-year, reaching $226.7 million.
Net loss improved to $(7.6) million compared to $(18.8) million in the same quarter last year.
Adjusted EBITDA was $12.3 million, a significant improvement from $(6.1) million in the third quarter of 2022.
Subscribers grew to 1.4 million, representing a 56% increase year-over-year.
For the fourth quarter 2023, the company expects revenue of $243 million to $248 million and Adjusted EBITDA of $14 million to $17 million. For the full year 2023, they expect revenue of $868 million to $873 million and Adjusted EBITDA of $43 million to $46 million.
Visualization of income flow from segment revenue to net income